Hemophilia B (patient information)

Jump to: navigation, search

For the WikiDoc page for this topic, click here

Haemophilia B
ICD-10 D67
ICD-9 286.1
OMIM 306900
DiseasesDB 5561
MedlinePlus 000539
MeSH D002836

WikiDoc Resources for Hemophilia B (patient information)

Articles

Most recent articles on Hemophilia B (patient information)

Most cited articles on Hemophilia B (patient information)

Review articles on Hemophilia B (patient information)

Articles on Hemophilia B (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemophilia B (patient information)

Images of Hemophilia B (patient information)

Photos of Hemophilia B (patient information)

Podcasts & MP3s on Hemophilia B (patient information)

Videos on Hemophilia B (patient information)

Evidence Based Medicine

Cochrane Collaboration on Hemophilia B (patient information)

Bandolier on Hemophilia B (patient information)

TRIP on Hemophilia B (patient information)

Clinical Trials

Ongoing Trials on Hemophilia B (patient information) at Clinical Trials.gov

Trial results on Hemophilia B (patient information)

Clinical Trials on Hemophilia B (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemophilia B (patient information)

NICE Guidance on Hemophilia B (patient information)

NHS PRODIGY Guidance

FDA on Hemophilia B (patient information)

CDC on Hemophilia B (patient information)

Books

Books on Hemophilia B (patient information)

News

Hemophilia B (patient information) in the news

Be alerted to news on Hemophilia B (patient information)

News trends on Hemophilia B (patient information)

Commentary

Blogs on Hemophilia B (patient information)

Definitions

Definitions of Hemophilia B (patient information)

Patient Resources / Community

Patient resources on Hemophilia B (patient information)

Discussion groups on Hemophilia B (patient information)

Patient Handouts on Hemophilia B (patient information)

Directions to Hospitals Treating Hemophilia B (patient information)

Risk calculators and risk factors for Hemophilia B (patient information)

Healthcare Provider Resources

Symptoms of Hemophilia B (patient information)

Causes & Risk Factors for Hemophilia B (patient information)

Diagnostic studies for Hemophilia B (patient information)

Treatment of Hemophilia B (patient information)

Continuing Medical Education (CME)

CME Programs on Hemophilia B (patient information)

International

Hemophilia B (patient information) en Espanol

Hemophilia B (patient information) en Francais

Business

Hemophilia B (patient information) in the Marketplace

Patents on Hemophilia B (patient information)

Experimental / Informatics

List of terms related to Hemophilia B (patient information)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-in-Chief: Alexandra M. Palmer

Overview

Hemophilia B is a hereditary bleeding disorder caused by a lack of blood clotting factor IX. Without enough factor IX, the blood cannot clot properly to control bleeding.

What are the symptoms of Hemophilia B?

The severity of symptoms can vary, and the severe forms become apparent early on.

Bleeding is the main symptom of the disease and sometimes, although not always, occurs if an infant is circumcised. Additional bleeding problems usually show up when the infant becomes mobile.

Mild cases may go unnoticed until later in life, when they occur in response to surgery or trauma. Internal bleeding may occur anywhere and bleeding into joints is common.

Symptoms can include:

What causes Hemophilia B?

Hemophilia B is caused by an inherited X-linked recessive trait, with the defective gene located on the X chromosome.

Females have two copies of the X chromosome, so if the factor IX gene on one chromosome is defective, the gene on the other chromosome can do the job of making enough factor IX.

Males, however, have only one X chromosome, so if the factor IX gene on that chromosome is defective, they will have Hemophilia B. Therefore, most people with hemophilia B are male.

If a woman has a defective factor IX gene, she is considered a carrier. This means the defective gene can be passed down to her children.

Boys born to a woman who carries the defective gene have a 50% chance of having hemophilia B, while their daughters have a 50% chance of being a carrier.

All female children of men with hemophilia carry the defective gene.

Who is at highest risk?

Risk factors for hemophilia B include:

When to seek urgent medical care?

Call your health care provider if:

Diagnosis

  • If the patient is the first person in the family to have a suspected bleeding disorder, he or she will undergo a series of tests called a coagulation study. Once the specific defect has been identified, other family members will need less testing to diagnose the disorder.
  • Tests results may include:

Treatment options

Standard treatment is infusion of factor IX concentrates to replace the defective clotting factor. The amount infused depends upon the severity of bleeding, the site of the bleeding, and the size of the patient.

To prevent a bleeding crisis, people with hemophilia and their families can be taught to administer factor IX concentrates at home at the first signs of bleeding. People with severe forms of the disease may need ongoing, preventive infusions.

Depending on the severity of the disease, factor IX concentrate may be given prior to dental extractions and surgery to prevent bleeding.

Hepatitis B vaccine is recommended for individuals with hemophilia B because they are at increased risk of developing hepatitis due to exposure to blood products.

Where to find medical care for Hemophilia B?

Directions to Hospitals Treating Hemophilia B

Prevention

Genetic counseling may be recommended. Testing can identify females who carry the hemophilia gene. Prenatal intrauterine tests can be done to determine if a developing baby has the disorder.

What to expect (Outlook/Prognosis)?

The outcome is usually good with treatment. Most people with hemophilia are able to lead relatively normal lives. A small number of people develop inhibitors of factor IX, and may die from loss of blood.

Patients with hemophilia B should establish regular care with a hematologist, especially one who is associated with a hemophilia treatment center. The ability to have quick and easy access to medical records documenting the patient's history of factor IX levels, factor transfusions (including the type and amount), complications, and amount of any inhibitors can be lifesaving in the event of an emergency situation.

Possible complications

Chronic joint deformities may occur from recurrent bleeding into the joint. These can be managed by an orthopedic specialist. However, joint replacement(s) may be needed.

Intracerebral hemorrhage (such as deep intracerebral hemorrhage and lobar intracerebral hemorrhage) may also occur.

Repeated transfusions may slightly raise the risk for HIV and hepatitis, however, continued improvements in blood screening procedures makes blood products safer than ever.

Thrombosis may occur following use of factor IX concentrate.

Source

http://www.nlm.nih.gov/medlineplus/ency/article/000539.htm


Linked-in.jpg